Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Vet Comp Oncol. 2013 May 15;13(3):246–254. doi: 10.1111/vco.12038

Figure 1.

Figure 1

Growth inhibition of representative canine tumour cell lines [including thyroid carcinoma (C-TAC), melanoma (CML-6M), mammary carcinoma (CMT-27) and osteosarcoma (D-17)] following treatment with GS-343074 in C/10. Dividing cells were exposed for 72 h (A) or 5 d (B) to increasing concentrations of GS-343074. Cell viability was determined using the MTS assay. The percentage of growth was normalized to the control cells exposed to C/10. Error bars represent the standard deviations calculated from four replicate experiments.